Poster Rounds with the Professors: Group E1
Professors: Diocesio Alves Pinto de Andrade, Brazil; Kohei Omatsu, Japan

1. MOLECULAR CLASSIFICATION OF ENDOMETRIAL CANCERS USING AN INTEGRATIVE DNA SEQUENCING PANEL
   Presenter: Soyoun Rachel Kim, Canada
2. ARE MISMATCH REPAIR DEFICIENT ENDOMETRIAL CANCER RECURRENCES MORE SALVAGEABLE THAN INTACT COHORT?
   Presenter: Soyoun Rachel Kim, Canada
3. PROGNOSTIC RELEVANCE OF THE MOLECULAR BASED ESMO/ESTRO/ESP2020 RISK CLASSIFICATION IN ENDOMETRIAL CARCINOMA AFTER SURGICAL LYMPH NODE STAGING
   Presenter: Teresa Praetorius, Germany

Poster Rounds with the Professors: Group E2                                                                                                                                                                  Professor: Ramez Eskander, USA

1. GENETIC TESTING FOLLOWING ABNORMAL IMMUNOHISTOCHEMISTRY RESULTS IN ENDOMETRIAL CANCER: A QUALITY IMPROVEMENT PROTOCOL
   Presenter: Hannah Karpel, USA
2. INTEGRATED PROFILING OF A PROSPECTIVE ENDOMETRIAL CANCER ORGANOID BIOBANK REVEALS HIGH HETEROGENEITY
   Presenter: Hege Berg, Norway
3. A CURRENT PERSPECTIVE ON ENDOMETRIAL CARCINOMA (EC) RISK CLASSIFICATION: RESULTS FROM AN EUROPEAN MULTICENTRE INITIATIVE.
   Presenter: Annika Rohner, Germany

Poster Rounds with the Professors: Group E3                                                                                                                                                                  Professors: Ana Oaknin, Spain; Angelica Nogueria Rodrigues, Brazil

1. HORMONAL BIOMARKERS REMAIN PROGNOSTIC RELEVANT WITHIN THE MOLECULAR CLASSIFICATION IN ENDOMETRIAL CANCER
   Presenter: Stephanie Vrede, Netherlands
2. IMMUNOMETABOLIC CHANGES DURING WEIGHT LOSS INDUCE TUMOR IMMUNOGENICITY RESULTING IN TUMOR REGRESSION
   Presenter: Martin Brennan, Ireland
3. IMMUNE-RELATED ENDPOINTS IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CANCER TREATED WITH DOSTARLIMAB IN THE GARNET STUDY
   Presenter: Ana Oaknin, Spain

Poster Rounds with the Professors: Group E4                                                                                                                                                            Professors: Nicoleta Colombo, Italy; Amanda Nickles Fader, USA

1. MOLECULAR LANDSCAPE OF ERBB2/HER2 GENE AMPLIFICATION AMONG PATIENTS WITH ENDOMETRIAL CARCINOMA.
   Presenter: Dimitrios Nasioudis, US
2. IS REFLEX MLH1 PROMOTER HYPERMETHYLATION TESTING FOLLOWING MLH1 LOSS BY IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL CARCINOMA BEST PRACTICE?
   Presenter: Anna Plotkin, Canada
3. MANAGEMENT OF IMMUNE-RELATED ADVERSE EVENTS IN PATIENTS WITH SOLID TUMORS TREATED WITH DOSTARLIMAB IN THE GARNET STUDY
   Presenter: Susana Banerjee, UK

Poster Rounds with the Professors: Group E5                                                                                                                                                            Professors: Pamela Soliman, USA; Arthur Hsu, Taiwan

1. SURVIVAL IMPACT OF ADJUVANT RADIOTHERAPY IN UTERINE CARCINOSARCOMA– A SEER BASED STUDY
   Presenter: Angela Jones, US
2. PROCEDURAL INTERVENTIONS FOR OLIGOPROGRESSION DURING TREATMENT WITH IMMUNE CHECKPOINT BLOCKADE IN GYNECOLOGIC MALIGNANCIES
   Presenter: Tiffany Sia, US

Poster Rounds with the Professors: Group C1                                                                                                                                                                Professors: Michelle Samora, Brazil; Jonathan Ledermann, UK

1. ONCOLYTIC ADENOVIRUS MEM-288 ENCODING MEMBRANE-STABLE CD40L AND IFN BETA INDUCES AN ANTI-TUMOR IMMUNE RESPONSE IN A HIGH GRADE SEROUS OVARIAN CANCER MOUSE MODEL
   Presenter: Pamela Peters, US
2. IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMA
   Presenter: Junsik Park, South Korea
3. ROLE OF GENOME-WIDE METHYLATION PROFILING OF CIRCULATING CELL-FREE DNA BY METHYLATED DNA SEQUENCING (MED-SEQ) IN ADVANCED-STAGE OVARIAN CANCER
   Presenter: Gatske Nieuwenhuyzen-de Boer, Netherlands

Poster Rounds with the Professors: Group C2                                                                                                                                                                        Professors: Domenica Larusso, Italy: Graziela Zibetti Dal Molin, Brazil;

1. DOSE-DENSE, WEEKLY PACLITAXEL AND CARBOPLATIN WITH OR WITHOUT BEVACIZUMAB, IN METASTATIC OR RECURRENT CERVICAL CARCINOMA (FINAL ANALYSIS OF JCOG1311)
   Presenter: Mitsuya Ishikawa, Japan
2. COST-EFFECTIVENESS OF PEMBROLIZUMAB FOR FIRST-LINE TREATMENT IN PATIENTS WITH PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER IN THE UNITED STATES
   Presenter: Bradley Monk, US
3. THE PROGNOSTIC VALUE OF PRESENCE OF PELVIC AND/OR PARA-AORTIC LYMPH NODE METASTASES IN CERVICAL CANCER PATIENTS; INFLUENCE OF THE NEW FIGO CLASSIFICATION (STAGE IIIC)
   Presenter: Kim van Kol, Netherlands

Poster Rounds with the Professors: Group C3                                                                                                                                                                Professors: Nomonde Mbatani, South Africa; Dong-Hoon Suh, Korea

1. THE DIAGNOSTIC ACCURACY OF COLPOSCOPY FOR CERVICAL INTRAEPITHELIAL NEOPLASIA 2+ AMONG HIV POSITIVE AND NEGATIVE SOUTH AFRICAN WOMEN.
   Presenter: Greta Dreyer, South Africa
2. INTEGRATING CERVICAL CANCER SCREENING WITH VOLUNTARY FAMILY PLANNING IN MOZAMBIQUE: THE MULHER STUDY
   Presenter: Mila P. Salcedo,  US
3. TISSUE-SPECIFIC METHYLATED DNA MARKER DISCRIMINATE AMONG ENDOMETRIAL, OVARIAN, AND CERVICAL CANCERS
   Presenter: Jessica Weng, US

Poster Rounds with the Professors: Group C4                                                                                                                                                                        Profesors: David Gershenson, USA; Eduardo Paulino, Brazil

1. FERTILITY-SPARING SURGERY IN STAGE I OVARIAN DYSGERMINOMA – THE ROLE OF SURGICAL AND RADIOLOGICAL STAGING
   Presenter: Diletta Fumagalli, Italy
2. ONCOLOGIC OUTCOME OF PATIENTS WITH STAGE I IMMATURE TERATOMA TREATED WITH SURVEILLANCE OR ADJUVANT CHEMOTHERAPY
   Presenter: Giuseppe Marino, Italy
3. THE IMPACT OF 2020 COVID-19 OUTBREAK ON THE TREATMENT PATTERNS OF CERVICAL CANCER IN BRAZILIAN PUBLIC HEALTH SYSTEM
   Presenter: Maria Amelia Borba, Brazil
4. THE ROLE OF POSTOPERATIVE RADIATION AFTER RADICAL HYSTERECTOMY FOR WOMEN WITH EARLY-STAGE NEUROENDOCRINE CARCINOMA OF THE CERVIX: A META-ANALYSIS
   Presenter: Catherine Kim, US

Poster Rounds with the Professors: Group C5                                                                                                                                                                        Professors: Ritu Salani, USA; Agnaldo Lopes, Brazil

1. PATTERNS OF PALLIATIVE CARE UTILIZATION BY WOMEN WITH GYNECOLOGIC MALIGNANCIES IN ONTARIO, CANADA: A 13-YEAR POPULATION-BASED RETROSPECTIVE ANALYSIS
   Presenter: Sarah J. Mah, Canada
2. QUANTITY OVER EQUITY: DISPARITIES IN THE DISTRIBUTION OF THE U.S. GYNECOLOGIC ONCOLOGY WORKFORCE
   Presenter: Nerlyne Desravines, US
3. ENHANCED RECOVERY AFTER SURGERY IN OPEN ABDOMINAL HYSTERECTOMY FOR MALIGNANT AND BENIGN DISEASE: A RANDOMISED CONTROL TRIAL
   Presenter: Shalini Rajaram, India

Poster Rounds with the Professors: Group O7                                                                                                                                                                        Professors: Roberto Angioli, Italy: Helen MacKay, Canada

1. PREDICTION MODEL FOR COMPLETE CYTOREDUCTION AT PRIMARY CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN CANCER BY INTEGRATING OF 18F-FDG PET/CT PARAMETERS AND CA-125
   Presenter: Se Ik Kim, South Korea
2. COST STUDY OF PLASMAJET SURGICAL DEVICE VERSUS CONVENTIONAL CYTOREDUCTIVE SURGERY IN ADVANCED-STAGE OVARIAN CANCER PATIENTS
   Presenter: Gatske Nieuwenhuyzen-de Boer, Netherlands

Poster Rounds with the Professors: Group O1                                                                                                                                                                     Professors: Frederick Haynes Van de Merwe, South Africa; Bruno Azevedo, Brazil

1. THE VALUE OF PET/CT FOR CYTOREDUCTIVE SURGERY SELECTION IN RECURRENT OVARIAN CARCINOMA
   Presenter: Glauco Baiocchi, Brazil
2. PREOPERATIVE CT SCORE FOR PREDICTING COMPLETE GROSS RESECTION AT PRIMARY AND INTERVAL DEBULKING SURGERY OF ADVANCED OVARIAN CANCER DURING THE COVID19 PANDEMIC
   Presenter: Yun Wang, Norway

Poster Rounds with the Professors: Group O2                                                                                                                                                                          Professor: Mansoor Mirza, Denmark

1. COST-EFFECTIVENESS OF HYSTERECTOMY AT THE TIME OF RISK-REDUCING BILATERAL SALPINGOOOPHORECTOMY FOR PATIENTS WITH BRCA1 MUTATIONS
   Presenter: Shayan Dioun, US
2. TRENDS IN THE INCIDENCE OF OVARIAN GERM CELL CANCERS IN US ASIANS AND NATIVE CHINESE
   Presenter: Chinmayi Aryasomayajula, US
3. TRENDS IN PHASE 3 CLINICAL TRIALS IN OVARIAN CANCER FROM 2001-2021
   Presenter: Arya Aliabadi, US

Poster Rounds with the Professors: Group O3                                                                                                                                                                      Professors: Isabelle Ray-Coquard, France; Linus Chuang, USA

1. ASSESSING ROBUSTNESS OF AN ARTIFICIAL INTELLIGENCE DERIVED HISTOLOGICAL BIOMARKER ACROSS DIFFERENT SITES OF DISEASE AND IN SERIAL SECTIONS IN TUBO-OVARIAN HIGH-GRADE SEROUS CARCINOMA
   Presenter: Ekin Tiu, US
2. PREDICTING RESPONSE TO PLATINUM-BASED CHEMOTHERAPY FOR TUBO-OVARIAN HIGH-GRADE SEROUS CARCINOMA USING AN ARTIFICIAL INTELLIGENCE HISTOPATHOLOGY PLATFORM
   Presenter: Ekin Tiu, US
3. HOMOLOGOUS RECOMBINATION DEFICIENCY AND CYCLIN E1 AMPLIFICATION ARE CORRELATED WITH IMMUNE CELL INFILTRATION AND SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCER
   Presenter: Lilian van Wagensveld, Netherlands

Poster Rounds with the Professors: Group O4                                                                                                                                                                 Professors: David O’Malley, USA; Andreia Melo, Brazil

1. PHASE 2 RESULTS OF RELACORILANT + NAB-PACLITAXEL IN PATIENTS WITH RECURRENT, PLATINUM-RESISTANT OVARIAN CANCER WITH AND WITHOUT PRIOR BEVACIZUMAB
   Presenter: Nicoletta Colombo, Italy
2. FIRST-LINE MAINTENANCE AMONG ADVANCED OVARIAN CANCER PATIENTS IN THE US ONCOLOGY NETWORK: A REAL-WORLD RETROSPECTIVE COHORT STUDY
   Presenter: Dana Chase, US
3. MIRVETUXIMAB SORAVTANSINE AND CARBOPLATIN FOR TREATMENT OF PATIENTS WITH RECURRENT FOLATE RECEPTOR ALPHA-POSITIVE PLATINUM-SENSITIVE OVARIAN CANCER: A FINAL ANALYSIS
   Presenter: Kathleen Moore, US

Poster Rounds with the Professors: Group O5                                                                                                                                                                    Professors: Andreas Du Bois, Germany; Glauco Baiocchi, Brazil

1. THE IMPACT OF UTILIZATION INDOCYANINE GREEN FOR ANASTOMOTIC PERFUSION ASSESSMENT ON THE RATE OF DIVERTING ILEOSTOMY IN PATIENTS WITH ADVANCED OVARIAN CANCER
   Presenter: Lina Salman, Canada
2. FIRST CLINICAL STUDY REPORTING ADOPTION OF ERAS IN CRS HIPEC AS PER PUBLISHED GUIDELINES: TIME TO ADOPT, EVOLVE & IMPROVE
   Presenter: Somashekhar SP, India

Poster Rounds with the Professors: Group O6                                                                                                                                                                 Professors: Jung-Yun Lee, Korea; Somashekhar SP, India

1. PREDICTION OF PLATINUM-BASED CHEMOTHERAPY RESISTANCE IN EPITHELIAL OVARIAN CANCER USING APPARENT DIFFUSION COEFFICIENT OF MAGNETIC RESONANCE IMAGE AND MACHINE LEARNING ALGORITHM
   Presenter: Jae Yeon Woo, South Korea
2. CRS-HIPEC IN UPFRONT VERSUS INTERVAL SETTING FOR ADVANCED EPITHELIAL OVARIAN CANCER – CUT WHEN FIT NOT WHEN FATIGUED
   Presenter: Somashekhar SP, India